首页> 外国专利> T-lymphocyte and T-lymphocyte receptor for immunococcal cancer

T-lymphocyte and T-lymphocyte receptor for immunococcal cancer

机译:T淋巴细胞和T淋巴细胞受体用于免疫球菌癌

摘要

This note refers to T lymphocyte (TCR) receptors attached to tumor antigens, which can specifically identify carcinogenic cells, T lymphocytes expressing cancer cells, methods of producing these cells and methods of handling these tumors. Specifically, this note refers to several TCR and their variants, which bind to one or two HLA molecules and attach a cucumber, such as igf2bp3-001 (SEQ ID n: 1), which contains the amino acid sequence of kiqeiltqv. In addition, this description also refers to cucumber and protein,Nucleic acids and cells are used in immunotherapy. In particular, this note refers to cancer immunotherapy. In addition, this description also refers to the cortitis of T lymphocytes associated with tumor, alone or in combination with other tumor related cucumbers, which can be used as the principle of active pharmacology in vaccine ingredients to stimulate anti-tumor immune response or stimulate immune response. Pre lymphocyte T, they will be transferred to the patient. Cucumbers are bound to molecules of the maximum histocompatibility (MHC) complex,Or cucumbers themselves, or antibody targets, soluble receptors of lymphocytes, and other combined molecules
机译:本注释是指与肿瘤抗原连接的T淋巴细胞(TCR)受体,可以特异性鉴定致癌细胞,表达癌细胞的T淋巴细胞,产生这些细胞的方法和处理这些肿瘤的方法。具体而言,该注释涉及几个TCR及其变体,它们与一个或两个HLA分子结合并连接一个黄瓜,例如igf2bp3-001(SEQ ID n:1),其中包含kiqeiltqv的氨基酸序列。另外,本说明书还涉及黄瓜和蛋白质,核酸和细胞被用于免疫治疗。特别地,该注释涉及癌症免疫治疗。另外,该描述还涉及与肿瘤相关的T淋巴细胞的皮质炎,其单独或与其他与肿瘤相关的黄瓜联合使用,可用作疫苗成分中的活性药理学原理,以刺激抗肿瘤免疫反应或刺激免疫。响应。前淋巴细胞T,它们将被转移给患者。黄瓜与最大组织相容性(MHC)复合物的分子或黄瓜本身或抗体靶标,淋巴细胞的可溶性受体及其他结合分子结合

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号